Health Care: Drugs

NovaBay Pharmaceuticals Inc (NBY: AMEX)

$3.9 n/a | n/a%
03/29/17 - 02:44 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 11.90M 4.38M 1.05M 3.48M
Cost of Sales 2.35M 1.10M 254.00K 162.00K
Gross Operating Profit 9.55M 3.28M 800.00K 3.31M
Selling, General, and Administrative Expenses 19.04M 18.53M 7.99M 6.34M
Research & Development 1.37M 5.73M 9.48M 12.46M
Operating Income before D & A (EBITDA) -10.87M -20.97M -16.67M -15.49M
Depreciation & Amortization 114.00K 164.00K 232.00K 314.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -2.17M 2.17M 1.71M -554.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -13.15M -18.97M -15.19M -16.35M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -13.15M -18.97M -15.19M -16.35M
Income Taxes 2.00K 2.00K 2.00K 2.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -13.15M -18.97M -15.19M -16.04M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -13.15M -18.97M -15.19M -16.04M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -13.15M -18.97M -15.19M -16.04M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-13.15M -18.97M -15.19M -16.04M
Preferred Dividends
Net Income Available To Common -13.15M -18.97M -15.19M -16.04M
Basic EPS from Continuing Ops. -1.40 -6.82 -7.65 -10.51
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.40 -6.82 -7.65 -10.51
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.40 -6.82 -7.65 -10.51
Basic Normalized Net Income/Share -1.40 -6.82 -7.65 -10.51
EPS fr Continuing Ops. -1.40 -6.82 -7.65 -10.51
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.40 -6.82 -7.65 -10.51
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.40 -6.82 -7.65 -10.51
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.40 -6.82 -7.65 -10.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NBY

Latest NBY Headlines from TheStreet

More Financial News for NBY

Press Releases for NBY

See All Press Releases

Partner Headlines for NBY

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter